Schwannoma Overview

Save information for later
Sign Up

Learn About Schwannoma

View Main Condition: Brain Tumor

What is the definition of Schwannoma?
A Schwannoma is a tumor of the peripheral nervous system or nerve root. A Schwannoma develops from cells called Schwann cells, a type of cell that wraps itself around peripheral nerves and provides protection and support. Schwannomas are almost always benign (not cancerous), but rarely, may become cancerous (a malignant Schwannoma). Symptoms of a Schwannoma may be vague and will vary depending on its location and size, but may include a lump or bump that can be seen or felt, pain, muscle weakness, tingling, numbness, hearing problems, and/or facial paralysis. Sometimes Schwannomas do not cause any symptoms. Schwannomas usually develop in otherwise healthy people for unknown reasons. In some cases, a Schwannoma is caused by a genetic disorder such as neurofibromatosis 2 (NF2), Schwannomatosis, or Carney complex. People with these genetic disorders usually have more than one Schwannoma. Schwannomas may be diagnosed using imaging studies. A biopsy may confirm the diagnosis.
What are the alternative names for Schwannoma?
  • Schwannoma
  • Benign schwannoma
  • Neurilemmoma
  • Neurilemoma
  • Neurolemmoma
  • Peripheral fibroblastoma
Who are the top Schwannoma Local Doctors?
Dr. Joshua R. Anderson
Neurosurgery
Dr. Joshua R. Anderson
Neurosurgery

Chi Health Clinic Specialty LLC

908 N Howard Ave, 108 Chi Health St Francis Spec Care, 
Grand Island, NE 
 (34.7 mi)
308-398-8994
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Joshua Anderson is a Neurosurgery provider in Grand Island, Nebraska. Dr. Anderson and is rated as an Experienced provider by MediFind in the treatment of Schwannoma. His top areas of expertise are Chronic Subdural Hematoma, Subdural Hematoma, Cervical Spondylosis, Laminectomy, and Microdiscectomy. Dr. Anderson is currently accepting new patients.

Dr. Benjamin R. Gelber
Neurosurgery
Dr. Benjamin R. Gelber
Neurosurgery

Neurological And Spinal Surgery LLC

2222 S 16th St, Suite 305, 
Lincoln, NE 
 (62.1 mi)
402-488-3002
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Benjamin Gelber is a Neurosurgery provider in Lincoln, Nebraska. Dr. Gelber and is rated as an Experienced provider by MediFind in the treatment of Schwannoma. His top areas of expertise are Meningioma, Essential Tremor, Klippel-Feil Syndrome, Deep Brain Stimulation, and Microdiscectomy. Dr. Gelber is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Dr. Steven L. Gogela
Neurosurgery
Dr. Steven L. Gogela
Neurosurgery

Neurological And Spinal Surgery LLC

2222 S 16th St, Suite 305, 
Lincoln, NE 
 (62.1 mi)
402-488-3002
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Steven Gogela is a Neurosurgery provider in Lincoln, Nebraska. Dr. Gogela and is rated as an Experienced provider by MediFind in the treatment of Schwannoma. His top areas of expertise are Spondylolisthesis, Delirium, Apoplexy, Nerve Decompression, and Laminectomy. Dr. Gogela is currently accepting new patients.

View All Doctors
What are the latest Schwannoma Clinical Trials?
Quality of Life and Decisional Regret in Patients Affected by Acoustic Neuroma
Quality of Life and Decisional Regret in Patients Affected by Acoustic Neuroma
Enrollment Status: Recruiting
Publish Date: February 25, 2025

Summary: Italian translation and validation study of two different questionnaire (VSQOL and DRS) about quality of life in patient with acoustic schwannoma.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Prospective Natural History Study of Patients With Neurofibromatosis Type 2 (NF2).
A Prospective Natural History Study of Patients With Neurofibromatosis Type 2 (NF2).
Enrollment Status: Recruiting
Publish Date: February 24, 2025

Summary: Objective With this prospective natural history study on neurofibromatosis type 2 (NF2) study, we hope to understand the factors leading to tumor progression and neurological disease burden in NF2. Study Population A total of 269 participants, ages 8-75, with a clinical or genetic diagnosis of NF2 will participate in this study. Design Study participants will be evaluated with a thorough physical ...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center